-
Sterilization continues to be a leading contraceptive choice for women in the United States; between 2006 and 2008, 10.3 million women looked to the method for birth control.
-
The Food and Drug Administration has given approval to Skyla, a new intrauterine system (IUS) from Bayer HealthCare Pharmaceuticals of Wayne, NJ. Available by prescription in February 2013, Skyla is the first new intrauterine contraceptive to receive U.S. approval in more than a decade.
-
-
Contraceptive injectables are a popular form of birth control for women around the world, with more than 35 million women relying on the method.
-
Since the July 2002 publication of the first Women's Health Initiative (WHI) report, many changes have been made in the approach to hormone therapy (HT).
-
In the wake of the 2012 elections, President Obama and members of Congress from both political parties declared immigration reform a top legislative priority.
-
Intrauterine devices (IUDs) are as safe for adolescents, including those who have never given birth, as they are for adults, according to just-published research.1
-
Sterilization remains the most popular form of contraception in the United States; 30.2% of couples rely on tubal sterilization for birth control, while 18.6% use oral contraceptives.1
-
Unrestricted access to emergency contraceptive pills (ECPs) remains blocked. The U.S. Department of Justice (DOJ) filed an appeal May 13, 2013, to delay the sale of ECPs to women of any age without a prescription.
-
The Centers for Disease Control and Prevention (CDC) now offers a free web-based self-study module, Genital Human Papillomavirus (HPV) Infection, as part of its Self-Study STD Modules for Clinicians series.
